Therefore, the aim of study was to assess the serum concentrations of GDF15, EGF, and neopterin in children with CKD on conservative treatment, to confront them with classical biochemical indicators of CKD-related complications, and to verify the usefulness of new markers in distinguishing between early and advanced stages of CKD using artificial intelligence tools. The gene discussed is EGF; the disease is chronic kidney disease.